ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,464Medicare Part D Prescriptions Filled, Including Refills

Rank: 54 out of 198

$682K Total Retail Price of All Prescriptions

Rank: 32 out of 198

410 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 410 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 410 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 7,663 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 536 412 1 1
SIMVASTATIN 312 272 2 2
OMEPRAZOLE 277 203 3 3
LISINOPRIL 259 223 4 6
FUROSEMIDE 251 208 5 5
HYDROCODONE-ACETAMINOPHEN 241 106 S3 6 8
SYNTHROID 206 139 7 36
ZOLPIDEM TARTRATE 195 163 8 22
AMLODIPINE BESYLATE 187 172 9 4
ATORVASTATIN CALCIUM 173 160 10 12
WARFARIN SODIUM 171 152 11 7
METOPROLOL SUCCINATE 168 143 12 11
TRAMADOL HCL 144 103 13 15
METOPROLOL TARTRATE 138 138 14 10
CITALOPRAM HBR 136 111 15 20
POTASSIUM CHLORIDE 133 89 16 9
GABAPENTIN 124 61 17 14
PRAVASTATIN SODIUM 107 92 18 19
ATENOLOL 106 93 19 17
METFORMIN HCL ER 106 78 19 64
NEXIUM 102 46 21 40
MIRTAZAPINE 101 87 22 44
TRIAMTERENE-HCTZ 99 82 23 32
METFORMIN HCL 99 61 23 13
SPIRONOLACTONE 97 48 25 37
CARVEDILOL 95 89 26 24
CYCLOBENZAPRINE HCL 83 27 R 27 67
PANTOPRAZOLE SODIUM 83 61 27 31
FLUOXETINE HCL 82 71 29 78
OXYCODONE HCL 82 15 S2 29 112
LOSARTAN POTASSIUM 80 71 31 18
VESICARE 78 44 32 77
TRAZODONE HCL 77 48 33 50
AMITRIPTYLINE HCL 77 44 R 33 69
CRESTOR 74 30 35 26
BENAZEPRIL HCL 73 73 36 45
HYDROCHLOROTHIAZIDE 70 59 37 16
DIGOXIN 70 70 37 43
ALLOPURINOL 69 66 39 23
SERTRALINE HCL 69 65 39 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 68 65 41 38
ONDANSETRON HCL 64 54 42 256
CIPROFLOXACIN HCL 60 55 43 55
VERAPAMIL ER 60 28 43 117
NAMENDA 59 59 45 33
AZITHROMYCIN 57 47 46 56
OXYCONTIN 57 40 S2 46 151
RANITIDINE HCL 56 31 48 54
CLONIDINE HCL 55 27 49 52
FLUCONAZOLE 53 24 50 193
MELOXICAM 53 48 50 30
DEXILANT 52 20 52 188
BUPROPION HCL SR 51 39 53 235
LOVASTATIN 51 39 53 70
LEVOFLOXACIN 50 44 55 81
CELEBREX 50 42 55 59
LANTUS SOLOSTAR 50 38 55 85
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 19, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.